Atrinius

N/A

Report date: 2024/12/03 15:10:01

Base Information

Drug NameAtrinius
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionAntithrombin-III replacements
TargetsUpdating
Therapy Area/IndicationsDisseminated Intravascular CoagulationAntithrombin III Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiogenius
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiogenius
Active IndicationsN/A
Inactive IndicationsDisseminated Intravascular CoagulationAntithrombin III Deficiency

Other Information

ATC CodeN/A
Related LinksN/A